Lukas Scheibler
Chief Tech/Sci/R&D Officer presso APELLIS PHARMACEUTICALS, INC.
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Lukas Scheibler is currently the Chief Research Officer at Apellis Pharmaceuticals, Inc. He previously worked as the Head-Clinical Development at Novartis Corp.
from 2002 to 2008.
From 2011 to 2015, he served as the Vice President at Alcon Laboratories, Inc. Additionally, he held the position of Executive Vice President-Translational Medicine at Acucela, Inc. from 2015 to 2017.
Dr. Scheibler obtained a graduate degree from the University of Basel and a doctorate degree from the University of Lausanne.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/12/2023 | 68 299 ( 0.06% ) | 4 M $ | 31/03/2024 |
Posizioni attive di Lukas Scheibler
| Società | Posizione | Inizio |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Lukas Scheibler
| Società | Posizione | Fine |
|---|---|---|
| ACUCELA INC | Corporate Officer/Principal | 01/12/2017 |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | 01/07/2015 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 01/06/2008 |
Formazione di Lukas Scheibler
| University of Basel | Graduate Degree |
| University of Lausanne | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Lukas Scheibler
